A detailed history of Tiemann Investment Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Tiemann Investment Advisors, LLC holds 3,500 shares of NVO stock, worth $174,230. This represents 0.1% of its overall portfolio holdings.

Number of Shares
3,500
Previous 3,500 -0.0%
Holding current value
$174,230
Previous $243,000 0.82%
% of portfolio
0.1%
Previous 0.11%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025

SELL
$69.3 - $90.95 $17,325 - $22,737
-250 Reduced 6.67%
3,500 $243,000
Q3 2024

Nov 14, 2024

SELL
$119.07 - $145.42 $35,721 - $43,625
-300 Reduced 7.41%
3,750 $446,000
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $184,153 - $404,068
2,025 Added 100.0%
4,050 $368,000
Q1 2022

May 13, 2022

SELL
$93.1 - $112.54 $69,825 - $84,405
-750 Reduced 27.03%
2,025 $225,000
Q2 2021

Aug 13, 2021

BUY
$67.66 - $84.76 $187,756 - $235,209
2,775 New
2,775 $232,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $112B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Tiemann Investment Advisors, LLC Portfolio

Follow Tiemann Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiemann Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tiemann Investment Advisors, LLC with notifications on news.